1H-Benzimidazole, 6-(4-Morpholinylmethyl)-2-(4-nitro-1H-pyrazol-3-yl)-结构式
|
常用名 | 1H-Benzimidazole, 6-(4-Morpholinylmethyl)-2-(4-nitro-1H-pyrazol-3-yl)- | 英文名 | 1H-Benzimidazole, 6-(4-Morpholinylmethyl)-2-(4-nitro-1H-pyrazol-3-yl)- |
|---|---|---|---|---|
| CAS号 | 825619-29-2 | 分子量 | 328.32600 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C15H16N6O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 4-[[2-(4-nitro-1,2-dihydropyrazol-3-ylidene)benzimidazol-5-yl]methyl]morpholine |
|---|
| 分子式 | C15H16N6O3 |
|---|---|
| 分子量 | 328.32600 |
| 精确质量 | 328.12800 |
| PSA | 115.65000 |
| LogP | 2.15450 |
|
~59%
1H-Benzimidazol... 825619-29-2 |
| 文献：ASTEX THERAPEUTICS LIMITED Patent: WO2007/77435 A1, 2007 ; Location in patent: Page/Page column 205 ; WO 2007/077435 A1 |
|
~%
1H-Benzimidazol... 825619-29-2 |
| 文献：Zheng, Youguang; Zheng, Ming; Ling, Xin; Liu, Yi; Xue, Yunsheng; An, Lin; Gu, Ning; Jin, Min Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 12 p. 3523 - 3530 |
|
~%
1H-Benzimidazol... 825619-29-2 |
| 文献：Zheng, Youguang; Zheng, Ming; Ling, Xin; Liu, Yi; Xue, Yunsheng; An, Lin; Gu, Ning; Jin, Min Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 12 p. 3523 - 3530 |
|
~%
1H-Benzimidazol... 825619-29-2 |
| 文献：Zheng, Youguang; Zheng, Ming; Ling, Xin; Liu, Yi; Xue, Yunsheng; An, Lin; Gu, Ning; Jin, Min Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 12 p. 3523 - 3530 |
|
~%
1H-Benzimidazol... 825619-29-2 |
| 文献：Zheng, Youguang; Zheng, Ming; Ling, Xin; Liu, Yi; Xue, Yunsheng; An, Lin; Gu, Ning; Jin, Min Bioorganic and Medicinal Chemistry Letters, 2013 , vol. 23, # 12 p. 3523 - 3530 |
